• CCO
• HIV
• Live Events
• Integrase Inhibitors

Washington Convention Center
Room 146
Washington, DC

Thank you for your interest in this live program. Registration is closed, as the current schedule has been completed. Please email info@clinicaloptions.com for more information.

Expert faculty members review the role of integrase in HIV replication, clinical trials of integrase inhibitors, and the use of integrase inhibitors in patient management, followed by discussion of clinical cases.

• Agenda
• Faculty
• CME Information
• Accreditation

Event Date	Details
Saturday, October 25, 2008	7:30 PM - 10:00 PM Local Time Registration and Reception 7:30 PM - 8:00 PM Symposium 8:00 PM - 10:00 PM

Agenda

7:30 PM - 8:00 PM Registration and Reception

8:00 PM - 8:05 PM Introductions and CME
Martin Markowitz, MD

8:05 PM - 8:20 PM Targeting Integrase: Mechanisms of Action and Mechanisms of Resistance to Integrase Inhibitors
Daniel R. Kuritzkes, MD

8:20 PM - 8:40 PM Clinical Studies of Integrase Inhibitors
Martin Markowitz, MD

8:40 PM - 9:00 PM From Bench to Bedside: The Clinical Role of Integrase Inhibitors
Eric S. Daar, MD

9:00 PM - 9:30 PM Case Discussions:
Audience polling and faculty discussion

• Constructing a New Regimen for a Highly Treatment-Experienced Patient With Multidrug Resistance
• Treatment of a Patient With Transmitted Drug Resistance and Intolerance to a Variety of Regimens
• Considering Regimens for a Patient With Very Limited Treatment Options
  
  

9:30 PM - 10:00 PM Concluding Panel: Audience Q&A; evaluations due

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.